study aims to evaluate the effectiveness of the postural fitness group via outcome data taken over a two-year period. Methods: A six-week (once weekly) postural fitness group was run by our paediatric physiotherapy team. The group consisted of exercises based on the APPI pilates series and weekly education -covering topics of stretching, seven key elements, back care and staying active. All patients referred to the postural fitness group for problems relating to poor postural awareness and/or trunk weakness, from January 2016 to December 2017 aged 11-16 years old with an identified weakness were included. Patients completed either two or three outcome measures -the Measure Yourself Medical Outcome profile (MYMOP), Roland Morris Disability Questionnaire (RMDQ) and an end of group questionnaire. Results: 13 groups ran in 2016/2017 with 81 patients referred. 19 patients were not brought (WNB) to the group at all. Of the 62 that attended the groups, 77% (n ¼ 48) completed the whole six-week course. MYMOP results comparison from pre-group to post group demonstrated improvements in all sections, with a 1-point average improvement in symptoms, and a 2-point average improvement in general wellbeing. In the RMDQ there was an average improvement of three points over the six weeks. The post group questionnaire showed that 96% found the group useful, very useful or invaluable. The questionnaire also showed an improvement in sporting activity -those who felt they were able to participate in sport with minimal caution or participate fully increased from 27% pre-group to 69% after completion of the group. In addition, 100% of patients felt that they could use the exercises and advice independently if the problem re-occurred in the future.
RESEARCH PROJECT PROPOSAL P14 DOES ART THERAPY MAKE
Background: Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that is associated with psoriasis and can include a potential co-occurrence of enthesitis, dactylitis and involvement of the nails. The heterogeneity of this disease makes comprehensive assessment a challenge in clinical practice as it involves monitoring both skin and joint parameters, alongside the associated co-morbid features. Whilst different tools have been used for measuring the disease activity in patients with PsA, bringing this all together under one umbrella will be of practical benefit to monitor this long term multi-faceted condition. Methods: The aim of this project was to bring together the validated tools to measure individual disease activity in PsA based on patient reported outcomes as well as joint and skin assessment by physicians, and to evaluate its use in paediatric PsA patients. A new simplified tool aimed at both patients and physicians was designed and piloted in the setting of a paediatric psoriatic arthritis clinic. The data collected included: the number of swollen and restricted joints, patient pain and physician global assessment ratings, Childhood Health Assessment Questionnaire (CHAQ), Psoriasis area Severity Index (PASI), Children's Dermatology Life Quality Index (CDLQI) and Minimal Disease Activity (MDA) alongside annual blood monitoring and screening for comorbidities. Both patients and physicians had the opportunity to complete their respective sections of the unified proforma. Results: Fifteen patients/parents were supplied with feedback forms at the end of the clinic in which all reported that the profoma was simple to use and they felt included in management of their care. Additionally, the physicians reported that the questionnaire was easy to follow and proved to be effective for the evaluation of PsA in the paediatric setting. Conclusion: The unified and comprehensive disease monitoring tool is a practical way of collecting and recording data. This should be useful for clinical management and future research in paediatric onset psoriatic arthritis. 
